Ordering
Available Variants50 mg
CHA.97779-50mg
Price
€66.32
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.97779-50mg | €66.32 |
analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C19H26I3N3O9 |
|---|---|
| CAS Number | 66108-95-0 |
| Molecular Weight | 821.14 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| PubChem Substance ID | 329765500 |
| EC Number | 266-164-2 |
| Beilstein/REAXYS Number | 2406632 |
| MDL number | MFCD00077732 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 1 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Iohexol, with a CAS number of 66108-95-0, is a non-ionic, monomeric iodinated contrast agent commonly utilized in medical imaging procedures, including computed tomography and radiography. It functions by absorbing x-rays, thereby enhancing the contrast of structures or fluids within the body, which facilitates the diagnosis of various medical conditions. Iohexol is typically administered via intravenous injection, and its distribution and excretion are primarily governed by glomerular filtration. The compounds pharmacokinetic profile is characterized by rapid distribution and elimination, with the majority being excreted unchanged in the urine within 24 hours. Iohexols safety profile and efficacy have been extensively evaluated, and it is generally well-tolerated, although adverse reactions can occur, particularly in patients with pre-existing renal impairment or a history of allergic reactions to iodinated contrast agents.
